Thursday, 18 July 2019

Specials News

  • Sigma Pharma leverages on its pharmacy business

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained its No 3 rank slot in the BioSpectrum Asia list of Top 20 publicly lis...Read more

  • M&A activity slows down in APAC

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    In 2011, the number of mergers and acquisitions in the life sciences field of Asia Pacific witnessed a fall. An independent M&A intelligence service mergermarket noted that the number ...Read more

  • Shenzhen Neptunus invests in drug innovation

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical products in China. The company is known for manufacturing approximately 400 ...Read more

  • Sudha Rao: Your decisions are milestones of your life's journey

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    I completed my graduation and post graduation from the University of Mysore. My first job, after my post doctoral studies in neurobiology at Cornell Medical School, was at Quark Biotech in ...Read more

  • Pharma industry expected to fragment

    Specials |  News | By Nandita Singh | 0 Comment | 13 Mar, 2012

    "2012 will be the year when the pharma industry will begin to fragment rather than consolidate. The trend of companies breaking up R&D into smaller, leaner units and, in some cases, mak...Read more

  • Existing TB treatments take too long to be effective'

    Specials |  News | By Rahul Koul Koul | 0 Comment | 12 Mar, 2012

    Microbial geneticist Dr Gyanu Lamichhane of the Johns Hopkins Center for Tuberculosis Research is one of the foremost authority in tuberculosis reseach in the world. He has received many aw...Read more

  • How real is the threat of TDR-TB?

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 23 Mar, 2012

    The latest concern to have plagued the field of TB is the emergence of total drug resistant TB (TDR-TB). Until 50 years ago, there were no medicines to cure TB. Now, strains that are resist...Read more

  • China, Australia dominate APAC pharma market

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 2011, riding on various factors, including an ever increasing population...Read more

  • IKP's Deepanwita Chattopadhyay: Women, open up your mind

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2013

    We were a large family with my parents, seven brothers and sisters, and our dog. Life was always busy - there was no way one could get bored - with studies, dance, music, painting, playing,...Read more

  • Big Pharma continues acquisitions

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month for M&A activity, with companies making transactions for more th...Read more

  • Bindhya Cariappa: A woman has many roles to play

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    My father was an army officer and we saw frequent relocation, as a result of which we learned very early in life to adapt to a new environment every few years. This has been helpful in keep...Read more

  • Biopectrum award winner Novo Informatics brings speed to drug discovery

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Novo Informatics is the brainchild of a group of students and researchers from the Indian Institute of Technology (IIT), Delhi, a premier academic institution in India. Mr Sahil Kapoor, Mr ...Read more

  • China National Accord's R&D strategy begins to pay-off

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scientific development by implementing new medical reforms fostered by Chine...Read more

  • Challenge No 10: Lack of mid-size CROs

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    For the CRO industry, the biggest challenge will be to develop a credible mid-sized offering to the industry. Currently, this does not exist. (Read about all 10 challenges for businesses in...Read more

  • Challenge No 3: Policy issues

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Government policies are among the major challenges before companies operating in the life sciences sector in the Asia Pacific region. For larger multinationals, policies favouring local com...Read more

  • India's 127-year-old ayurvedic leader clocks $847 mn

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufacturing traditional ayurvedic products that passes rigorous trials and au...Read more

  • What were the top 20 global M&A transactions of 2012?

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek out partners for mergers &am...Read more

  • BioSpectrum Technology Forum 2015 concludes successfully

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 25 Aug, 2015

    BioSpectrum Technology Forum 2015 was successfully concluded on August 14th, 2015 at The Taj Krishna, Hyderabad. Team BioSpectrum would like to express our heartfelt thanks to the Speakers ...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls